Analytical limitations in the quantification of insulin and C-peptide in blood samples create problems for using the ratio of insulin to C-peptide, an interesting hypothetical value that could be used to distinguish between hypoglycemia due to exogenous or endogenous insulin. The gene discussed is INS; the disease is Hypoglycemia.